These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 25023392)

  • 21. Vibrio cholerae ghosts (VCG) exert immunomodulatory effect on dendritic cells for enhanced antigen presentation and induction of protective immunity.
    Eko FO; Mania-Pramanik J; Pais R; Pan Q; Okenu DM; Johnson A; Ibegbu C; He C; He Q; Russell R; Black CM; Igietseme JU
    BMC Immunol; 2014 Dec; 15():584. PubMed ID: 25551828
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The vaccine adjuvant alum inhibits IL-12 by promoting PI3 kinase signaling while chitosan does not inhibit IL-12 and enhances Th1 and Th17 responses.
    Mori A; Oleszycka E; Sharp FA; Coleman M; Ozasa Y; Singh M; O'Hagan DT; Tajber L; Corrigan OI; McNeela EA; Lavelle EC
    Eur J Immunol; 2012 Oct; 42(10):2709-19. PubMed ID: 22777876
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Manipulating the antigen-specific immune response by the hydrophobicity of amphiphilic poly(γ-glutamic acid) nanoparticles.
    Shima F; Akagi T; Uto T; Akashi M
    Biomaterials; 2013 Dec; 34(37):9709-16. PubMed ID: 24016848
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Poly[di(carboxylatophenoxy)phosphazene] (PCPP) is a potent immunoadjuvant for an influenza vaccine.
    Payne LG; Jenkins SA; Woods AL; Grund EM; Geribo WE; Loebelenz JR; Andrianov AK; Roberts BE
    Vaccine; 1998 Jan; 16(1):92-8. PubMed ID: 9607015
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunology of TLR-independent vaccine adjuvants.
    De Gregorio E; D'Oro U; Wack A
    Curr Opin Immunol; 2009 Jun; 21(3):339-45. PubMed ID: 19493664
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alum-functionalized graphene oxide nanocomplexes for effective anticancer vaccination.
    Wang X; Cao F; Yan M; Liu Y; Zhu X; Sun H; Ma G
    Acta Biomater; 2019 Jan; 83():390-399. PubMed ID: 30448435
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fluorine-Functionalized Polyphosphazene Immunoadjuvant: Synthesis, Solution Behavior and In Vivo Potency.
    Tagad HD; Marin A; Wang R; Yunus AS; Fuerst TR; Andrianov AK
    Molecules; 2023 May; 28(10):. PubMed ID: 37241958
    [TBL] [Abstract][Full Text] [Related]  

  • 28. TLR7 triggering with polyuridylic acid promotes cross-presentation in CD8α+ conventional dendritic cells by enhancing antigen preservation and MHC class I antigen permanence on the dendritic cell surface.
    Crespo MI; Zacca ER; Núñez NG; Ranocchia RP; Maccioni M; Maletto BA; Pistoresi-Palencia MC; Morón G
    J Immunol; 2013 Feb; 190(3):948-60. PubMed ID: 23284054
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human Flt-3-ligand-mobilized dendritic cells require additional activation to drive effective immune responses.
    Diener KR; Moldenhauer LM; Lyons AB; Brown MP; Hayball JD
    Exp Hematol; 2008 Jan; 36(1):51-60. PubMed ID: 17949888
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analysis of the role of vaccine adjuvants in modulating dendritic cell activation and antigen presentation in vitro.
    Sun H; Pollock KG; Brewer JM
    Vaccine; 2003 Feb; 21(9-10):849-55. PubMed ID: 12547593
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Polycation-decorated PLA microspheres induce robust immune responses via commonly used parenteral administration routes.
    Chen X; Wang L; Liu Q; Jia J; Liu Y; Zhang W; Ma G; Su Z
    Int Immunopharmacol; 2014 Dec; 23(2):592-602. PubMed ID: 25466267
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lumenal part of the DC-LAMP protein is not required for induction of antigen-specific T cell responses by means of antigen-DC-LAMP messenger RNA-electroporated dendritic cells.
    De Keersmaecker B; Heirman C; Allard S; Bonehill A; Corthals J; Thielemans K; Aerts JL
    Hum Gene Ther; 2010 Apr; 21(4):479-85. PubMed ID: 19903083
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antigen depot is not required for alum adjuvanticity.
    Hutchison S; Benson RA; Gibson VB; Pollock AH; Garside P; Brewer JM
    FASEB J; 2012 Mar; 26(3):1272-9. PubMed ID: 22106367
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human dendritic cell interactions with whole recombinant yeast: implications for HIV-1 vaccine development.
    Barron MA; Blyveis N; Pan SC; Wilson CC
    J Clin Immunol; 2006 May; 26(3):251-64. PubMed ID: 16783464
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enhanced non-inflammasome mediated immune responses by mannosylated zwitterionic-based cationic liposomes for HIV DNA vaccines.
    Qiao C; Liu J; Yang J; Li Y; Weng J; Shao Y; Zhang X
    Biomaterials; 2016 Apr; 85():1-17. PubMed ID: 26851653
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Virological and immunological characterization of novel NYVAC-based HIV/AIDS vaccine candidates expressing clade C trimeric soluble gp140(ZM96) and Gag(ZM96)-Pol-Nef(CN54) as virus-like particles.
    Perdiguero B; Gómez CE; Cepeda V; Sánchez-Sampedro L; García-Arriaza J; Mejías-Pérez E; Jiménez V; Sánchez C; Sorzano CÓ; Oliveros JC; Delaloye J; Roger T; Calandra T; Asbach B; Wagner R; Kibler KV; Jacobs BL; Pantaleo G; Esteban M
    J Virol; 2015 Jan; 89(2):970-88. PubMed ID: 25355891
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Two-step maturation of immature DCs with proinflammatory cytokine cocktail and poly(I:C) enhances migratory and T cell stimulatory capacity.
    Kim HJ; Kim HO; Lee K; Baek EJ; Kim HS
    Vaccine; 2010 Apr; 28(16):2877-86. PubMed ID: 20156531
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pidotimod promotes functional maturation of dendritic cells and displays adjuvant properties at the nasal mucosa level.
    Giagulli C; Noerder M; Avolio M; Becker PD; Fiorentini S; Guzman CA; Caruso A
    Int Immunopharmacol; 2009 Nov; 9(12):1366-73. PubMed ID: 19712757
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activation of human monocyte-derived dendritic cells in vitro by the biological response modifier arabinoxylan rice bran (MGN-3/Biobran).
    Ghoneum M; Agrawal S
    Int J Immunopathol Pharmacol; 2011; 24(4):941-8. PubMed ID: 22230400
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modification of human embryonic stem cell-derived dendritic cells with mRNA for efficient antigen presentation and enhanced potency.
    Nishimoto KP; Tseng SY; Lebkowski JS; Reddy A
    Regen Med; 2011 May; 6(3):303-18. PubMed ID: 21548736
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.